Clinical Trials on 失语症,原发性进行性 in Japan
总计1030个结果
-
Janssen Pharmaceutical K.K.完全的
-
Eli Lilly and Company完全的
-
Daiichi Sankyo Co., Ltd.CMIC Co, Ltd. Japan完全的
-
Kiminori Kimura, MDJapan Agency for Medical Research and Development; Ohara Pharmaceutical Co., Ltd.完全的
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); University of California, San Francisco; Fred Hutchinson Cancer... 和其他合作者主动,不招人
-
Pfizer's Upjohn has merged with Mylan to form Viatris...终止
-
AstraZeneca撤销
-
International University of Health and WelfareJapan Agency for Medical Research and Development; Chugai Pharmaceutical; Keio University招聘中
-
Idorsia Pharmaceuticals Ltd.终止
-
Comprehensive Support Project for Oncology Research主动,不招人
-
Kyorin UniversityJapan Clinical Oncology Group招聘中
-
Merck Sharp & Dohme LLCOrion Corporation, Orion Pharma主动,不招人
-
University of YamanashiHuman Genome Center, Institute of Medical Science, University of Tokyo未知
-
Merck KGaA, Darmstadt, GermanyMerck Serono Co., Ltd., Japan完全的
-
Jichi Medical University完全的
-
Astellas Pharma Inc完全的
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company邀请报名肾脏疾病 | 泌尿系统疾病 | 遗传病 | 原发性高草酸尿症 1 型 (PH1) | 原发性高草酸尿症 2 型 (PH2) | 原发性高草酸尿症 3 型 (PH3)美国, 法国, 德国, 日本, 黎巴嫩, 西班牙, 英国, 澳大利亚, 加拿大, 意大利, 荷兰, 挪威, 火鸡
-
Astellas Pharma Inc完全的
-
Ferring Pharmaceuticals完全的
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); University of California, Los Angeles; Fred Hutchinson Cancer... 和其他合作者招聘中
-
Kyorin UniversityMinistry of Health, Labour and Welfare, Japan未知
-
Astellas Pharma IncMedivation LLC, a wholly owned subsidiary of Pfizer Inc.完全的